Bespoke Extracts, Inc. reported its financial results for the second quarter of 2025, revealing a total revenue of $390,553, a 40.4% increase from $278,163 in the same period last year. For the first half of 2025, the company generated $653,712 in sales, up from $538,591 in the first half of 2024. The increase in revenue was attributed to higher sales of pre-rolled joints and increased production services for third parties, driven by new product offerings. Despite the revenue growth, the company reported a net loss of $205,106 for the second quarter, compared to a loss of $260,895 in the prior year, and a total net loss of $465,627 for the first half of 2025, down from $575,013 in the same period last year.
Bespoke Extracts' operating expenses for the second quarter were $359,457, slightly higher than $356,360 in the previous year. The increase was primarily due to higher professional fees and payroll expenses, although stock-based compensation decreased significantly. The company's gross profit for the second quarter was $197,499, compared to $106,117 in the same quarter of 2024, reflecting improved efficiency in production as costs of goods sold rose at a slower rate than sales.
The company’s balance sheet as of June 30, 2025, showed total assets of $267,038, a decrease from $359,088 at the end of 2024. Current liabilities increased to $1,485,466, up from $1,118,671, largely due to higher accounts payable and accrued liabilities. The total stockholders' deficit widened to $2,539,306 from $2,091,938, indicating ongoing financial challenges. The company had cash reserves of only $1,363 at the end of the reporting period, down from $60,305 at the end of 2024, raising concerns about liquidity.
In terms of operational developments, Bespoke Extracts continues to focus on its core business in the regulated cannabis market, specifically in Colorado. The company has not reported any significant acquisitions or organizational changes in the recent quarter. However, it has emphasized the importance of generating profitable operations and securing additional financing to meet its obligations. The company’s management has expressed concerns about its ability to continue as a going concern, given its negative cash flows and working capital deficit.
Looking ahead, Bespoke Extracts aims to enhance its product offerings and expand its market presence. The management has indicated that future growth will depend on the successful launch of new products and the ability to secure necessary financing. The company remains cautious about market conditions and the potential impact of external factors, including the ongoing effects of the COVID-19 pandemic on operations and capital raising efforts.
About Bespoke Extracts, Inc.
Bespoke Extracts, Inc. operates in the regulated cannabis industry, primarily in Colorado, producing and distributing branded adult-use cannabis products such as pre-rolled joints under names like Fresh Joints, Doobskis, and Dutch Blunts. The company also offers processing services for licensed cultivators and dispensaries. It focuses on compliance with state regulations, quality assurance, and brand development to serve licensed marijuana dispensaries and adult consumers in the U.S. cannabis market.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.